Fluxergy Requests EUA for 1-Hour POC Covid-19 Test
In bench lab tests, the Fluxergy analyzer system, which utilizes PCR and microfluidics technology, has been shown to accurately identify the SARS-CoV-2 virus in less than 1 hour.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
In bench lab tests, the Fluxergy analyzer system, which utilizes PCR and microfluidics technology, has been shown to accurately identify the SARS-CoV-2 virus in less than 1 hour.
Read MorePosted by | Apr 2, 2020 | Blood Gas Analyzers, Clinical Chemistry, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read MorePosted by | Mar 30, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The DPP Covid-19 IgM/IgG system is a single-use rapid point-of-care test for the detection and differentiation of IgM and IgG antibodies to covid-19 in whole blood.
Read MorePosted by Steve Halasey | Mar 24, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The agency’s EUA grants permission for Cepheid’s test to be used in high- and moderate-complexity CLIA-certified laboratories as well as in certain patient care settings.
Read More